SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65 | +97.0% | 2,350 | +115.0% | 0.05% | +96.0% |
Q2 2023 | $33 | +6.5% | 1,093 | +26.7% | 0.02% | -7.4% |
Q1 2023 | $31 | – | 863 | +8530.0% | 0.03% | – |
Q4 2022 | $0 | -100.0% | 10 | -90.7% | 0.00% | -100.0% |
Q3 2022 | $4,000 | – | 108 | +1100.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 9 | -94.9% | 0.00% | -100.0% |
Q1 2022 | $6,000 | +50.0% | 177 | +16.4% | 0.00% | -33.3% |
Q4 2021 | $4,000 | – | 152 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |